Eads & Heald Investment Counsel reduced its stake in Stericycle Inc. (NASDAQ:SRCL) by 3.3% during the second quarter, Holdings Channel reports. The institutional investor owned 10,052 shares of the company’s stock after selling 343 shares during the period. Eads & Heald Investment Counsel’s holdings in Stericycle were worth $1,047,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. State Street Corp raised its position in Stericycle by 0.5% in the first quarter. State Street Corp now owns 3,593,337 shares of the company’s stock valued at $453,442,000 after buying an additional 19,317 shares in the last quarter. Jana Partners LLC acquired a new stake in Stericycle during the first quarter valued at approximately $305,997,000. Swedbank acquired a new stake in Stericycle during the second quarter valued at approximately $104,155,000. Geode Capital Management LLC increased its stake in Stericycle by 2.7% in the first quarter. Geode Capital Management LLC now owns 729,638 shares of the company’s stock valued at $91,897,000 after buying an additional 19,379 shares during the last quarter. Finally, Alecta Pensionsforsakring Omsesidigt increased its stake in Stericycle by 16.7% in the second quarter. Alecta Pensionsforsakring Omsesidigt now owns 700,000 shares of the company’s stock valued at $72,877,000 after buying an additional 100,000 shares during the last quarter. 92.76% of the stock is owned by hedge funds and other institutional investors.
Shares of Stericycle Inc. (NASDAQ:SRCL) traded up 1.46% during mid-day trading on Tuesday, hitting $75.27. The stock had a trading volume of 374,431 shares. The firm has a 50 day moving average of $79.91 and a 200-day moving average of $96.91. The stock has a market cap of $6.40 billion, a P/E ratio of 26.49 and a beta of 0.21. Stericycle Inc. has a one year low of $72.89 and a one year high of $151.57.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm earned $891.60 million during the quarter, compared to analysts’ expectations of $910.29 million. During the same period last year, the business posted $1.14 earnings per share. The company’s revenue for the quarter was up 24.6% compared to the same quarter last year. Equities research analysts expect that Stericycle Inc. will post $4.67 earnings per share for the current fiscal year.
Several equities research analysts recently commented on SRCL shares. Zacks Investment Research upgraded Stericycle from a “hold” rating to a “buy” rating and set a $119.00 price objective for the company in a report on Thursday, July 21st. Royal Bank Of Canada cut their price objective on Stericycle from $89.00 to $77.00 and set an “underperform” rating for the company in a research note on Monday, September 19th. RBC Capital Markets reiterated an “underperform” rating and set a $77.00 price objective (down from $89.00) on shares of Stericycle in a research note on Monday, September 19th. Jefferies Group reiterated a “buy” rating and set a $125.00 price objective on shares of Stericycle in a research note on Tuesday, August 23rd. Finally, Northcoast Research downgraded Stericycle from a “buy” rating to a “neutral” rating in a research note on Tuesday, September 20th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $103.54.
In related news, Director Rodney F. Dammeyer sold 10,188 shares of the firm’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total transaction of $871,074.00. Following the sale, the director now directly owns 10,188 shares of the company’s stock, valued at $871,074. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of the firm’s stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the sale, the executive vice president now directly owns 1,088 shares in the company, valued at $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is owned by insiders.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.